HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Ohashi Selected Research

Pneumonia (Pneumonitis)

3/2022Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Ohashi Research Topics

Disease

7Infections
01/2012 - 01/2004
5Multiple Sclerosis
04/2019 - 01/2011
3Neuromyelitis Optica (Devic's Disease)
01/2016 - 01/2011
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
11/2015 - 01/2004
3Vaccinia
02/2014 - 02/2009
2Neoplasms (Cancer)
11/2015 - 07/2004
2T-Cell Leukemia (Leukemia, T Cell)
03/2005 - 01/2004
1Chronic Progressive Multiple Sclerosis
05/2022
1Pneumonia (Pneumonitis)
03/2022
1Hematologic Neoplasms (Hematological Malignancy)
03/2022
1Acute Kidney Injury (Acute Renal Failure)
03/2022
1Febrile Neutropenia
03/2022
1Optic Neuritis (Retrobulbar Neuritis)
12/2021
1Relapsing-Remitting Multiple Sclerosis
04/2019
1Encephalitis (Encephalitis, Rasmussen)
11/2017
1Seizures (Absence Seizure)
11/2017
1Tuberculoma
01/2017
1Neurocysticercosis
01/2017
1Leukoencephalopathies
01/2016
1Neoplasm Metastasis (Metastasis)
11/2015
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2015
1Parkinson Disease (Parkinson's Disease)
06/2015
1Inflammation (Inflammations)
11/2014
1Human Influenza (Influenza)
01/2012
1Myxoma (Myxomas)
01/2011
1Cerebral Infarction
01/2011
1HTLV-I Infections (HTLV-I Infection)
10/2008
1Colonic Neoplasms (Colon Cancer)
05/2007
1Adenoma (Adenomas)
05/2007
1Polycythemia (Erythrocytosis)
06/2006
1Acute Erythroblastic Leukemia (Erythroleukemia)
06/2006
1Hyperplasia
06/2006
1Lymphoma (Lymphomas)
03/2005
1Vesicular Stomatitis
09/2004
1Thrombocytopenia (Thrombopenia)
02/2002
1Myelitis
02/2002

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
02/2014 - 03/2005
2MethylprednisoloneFDA LinkGeneric
01/2016 - 11/2014
2SteroidsIBA
11/2014 - 02/2002
2AntibodiesIBA
01/2012 - 01/2012
2Complementary DNA (cDNA)IBA
11/2004 - 01/2004
1siponimodIBA
05/2022
1Transaminases (Aminotransferases)IBA
03/2022
1arbekacinIBA
03/2022
1HLA-DRB1*04 antigenIBA
12/2021
1HLA-DRB1 Chains (HLA DRB1)IBA
12/2021
1Dimethyl FumarateIBA
04/2019
1dimemorfan (AT 17)IBA
11/2017
1Adenosine DeaminaseIBA
01/2017
1Interferon-gamma (Interferon, gamma)IBA
01/2017
1Praziquantel (Biltricide)FDA Link
01/2017
1GadoliniumIBA
01/2017
1Angiotensin Receptor AntagonistsIBA
01/2016
1OsteopontinIBA
11/2015
1IntegrinsIBA
11/2015
1SVVYGLR peptideIBA
11/2015
1DNA-Binding Proteins (DNA Binding Protein)IBA
06/2015
1SynucleinsIBA
06/2015
1CytokinesIBA
11/2014
1AIDS VaccinesIBA
02/2014
1GangliosidesIBA
01/2012
1Neutralizing AntibodiesIBA
01/2012
1Chemokine ReceptorsIBA
01/2011
1InterferonsIBA
01/2011
1Protein Isoforms (Isoforms)IBA
09/2010
1Antiviral Agents (Antivirals)IBA
05/2009
1DNA (Deoxyribonucleic Acid)IBA
02/2009
1gag Gene Products (gag Protein)IBA
02/2009
1EpitopesIBA
10/2008
1Peptides (Polypeptides)IBA
10/2008
1Viral RNAIBA
06/2007
1tannaseIBA
05/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2006
1ErythropoietinFDA Link
06/2006
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
06/2006
1Glycoproteins (Glycoprotein)IBA
06/2006
1proto-oncogene protein Spi-1IBA
06/2006
1IntegrasesIBA
11/2004
1specific substance maruyama (Z-100)IBA
09/2004
1Immunologic Factors (Immunomodulators)IBA
09/2004
1Small Interfering RNA (siRNA)IBA
01/2004
1Cardiolipins (Cardiolipin)IBA
02/2002

Therapy/Procedure

4Therapeutics
01/2016 - 07/2004
2Immunotherapy
11/2015 - 03/2005
2Hematopoietic Stem Cell Transplantation
07/2004 - 01/2004
1Plasmapheresis
11/2014
1Contraindications
01/2011
1Thrombolytic Therapy
01/2011
1Drug Therapy (Chemotherapy)
01/2004